Dexilant

Basic Dexilant Information

• INN (International Nonproprietary Name): Dexlansoprazole
• Brand Names Available In United Kingdom: Dexilant (may be marketed as dexlansoprazole by generic suppliers)
• ATC Code: A02BC06
• Forms & Dosages: Capsule, 30mg and 60mg, delayed‑release dual delayed gastric dissolution; packaging includes blister strips and bottles
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Rx Only

Read MHRA and NHS advice and your prescription label before use.

Dexilant is dexlansoprazole (INN) and is a prescription‑only proton pump inhibitor with a dual delayed‑release capsule formulation available in 30mg and 60mg strengths.

Store the capsules in their original packaging in a dry place below 30°C and protect from moisture and excessive heat.

If you take rilpivirine‑containing HIV medicines, or have acute severe liver failure, do not take dexlansoprazole and inform your prescriber.

If you miss a dose, take it when you remember unless it is close to the next dose; do not double up.

In the event of an overdose, seek emergency care; there is no specific antidote and supportive treatment is standard.

Long‑term PPI risks include low magnesium, vitamin B12 deficiency and a small increase in fracture risk; discuss continuing need with your clinician.

If you receive NHS prescriptions, remember charges vary across the UK with England usually charging and Scotland, Wales and Northern Ireland largely free.

Major UK pharmacy chains such as Boots, LloydsPharmacy and Superdrug commonly dispense Dexilant or generics.

For irregular meal schedules, the dual delayed‑release system makes timing more flexible than many other PPIs.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Is timing the reason your reflux returns mid‑day or at night?

Dexilant is designed for once‑daily dosing and typical NHS regimens are 30mg once daily for symptomatic GERD and 60mg once daily for healing erosive oesophagitis.

The healing dose for erosive oesophagitis is usually given for up to eight weeks, with maintenance often 30mg once daily for up to six months.

Because of the dual delayed‑release system, timing is more flexible than with many other proton pump inhibitors.

If daytime reflux predominates, morning dosing often suits daily routines and helps with daytime heartburn.

If nocturnal reflux is the problem, taking the capsule in the evening may give better overnight symptom coverage.

Take capsules whole and do not chew them as the delayed‑release beads must remain intact for proper action.

Taking With Or Without Meals (UK Diet Habits)

Can I take Dexilant with my full English or a late curry?

Dexilant may be taken with or without food, which helps when UK meal patterns vary between large breakfasts and variable evening meals.

If stomach upset occurs after taking the capsule, try taking it with a small snack to reduce nausea.

For people who miss a pre‑meal dosing window, the dual delayed‑release formulation decreases the need for strict meal‑timed dosing compared with many standard PPIs.

Checklist For Daily Dosing Habits:

• Decide whether reflux happens mainly by day or at night and pick morning or evening dosing accordingly.
• Take the capsule whole; do not crush or chew.
• If you forget a dose, take it when remembered unless it is nearly time for the next dose.
• Report persistent symptoms after 4 weeks on 30mg or after the prescribed course to your GP or pharmacist.

Quick Comparison: Dexilant Vs Standard PPIs On Meal Timing

Safety Priorities

Who Should Avoid It (MHRA Warnings)

Who needs to tell their prescriber before starting Dexilant?

Absolute contraindications include hypersensitivity to dexlansoprazole or excipients, co‑administration with rilpivirine and acute severe hepatic impairment.

Use caution with severe hepatic dysfunction; in moderate impairment use the lowest effective dose and avoid use in severe impairment due to limited data.

Discuss long‑term use with your clinician if you have osteoporosis, a history of fractures, low magnesium or vitamin B12 deficiency risk.

PPIs may mask symptoms of serious gastric disease such as gastric malignancy, so investigation should precede prolonged PPI therapy if alarm features exist.

Activities To Limit (Driving, Work Safety)

Can I drive or operate machinery when starting Dexilant?

Most people can drive and work normally while taking dexlansoprazole.

If you experience dizziness, severe drowsiness or confusion after starting treatment, avoid driving or hazardous tasks until symptoms resolve.

Shift workers and heavy machinery operators should document any new cognitive or coordination symptoms and report them promptly to their clinician.

Contraindications Checklist:

• Hypersensitivity to dexlansoprazole or other PPIs — avoid use.
• Concurrent use of rilpivirine-containing products — do not use together.
• Acute severe hepatic impairment — avoid use.

Work And Fitness‑To‑Drive Checklist:

• Note any new dizziness, drowsiness or visual disturbance after starting therapy.
• Avoid driving until you are certain you are not affected.
• Report side effects to your GP, pharmacist or via the MHRA Yellow Card scheme.

Dosage & Adjustments

General Regimen (NHS Guidance)

What dose will the NHS usually start with?

Standard adult dosing is 30mg once daily for symptomatic GERD, typically for up to four weeks.

Erosive oesophagitis is usually treated with 60mg once daily for up to eight weeks to achieve healing.

Maintenance therapy after healing commonly uses 30mg once daily for up to six months.

Children aged 12 years and older use the same dosing schedule as adults where indicated.

Dexilant remains prescription‑only and prescribers should follow local MHRA and NHS guidance when initiating therapy.

Special Cases (Elderly, Comorbidities)

Do older people or those with kidney or liver problems need different doses?

No routine dose adjustment is required for elderly patients, but monitor for increased sensitivity or adverse effects.

Renal impairment usually requires no dose change because dexlansoprazole is primarily metabolised in the liver.

In mild hepatic impairment no adjustment is needed, but in moderate hepatic impairment use the lowest effective dose and avoid use in severe hepatic impairment.

Review polypharmacy for interactions with atazanavir, clopidogrel and warfarin and adjust therapy or monitoring as necessary.

Dosage Summary Table

User Testimonials

Positive Reports From UK Patients

Do patients in the UK notice real benefits?

Many UK patients report rapid symptom relief for heartburn and particular improvement in nocturnal reflux with dexlansoprazole.

Users who previously needed precise timing with other PPIs commonly praise the reduced meal‑timing limitations with Dexilant.

Community pharmacy staff often relay patient satisfaction with fewer breakthrough reflux episodes and steadier symptom control.

Common Challenges (Patient.info, NHS Forums)

What do online forums say about side effects and costs?

Common challenges include mild GI side effects such as diarrhoea and nausea, occasional headaches and concerns about long‑term safety.

Discussion threads on Patient.info and NHS forums mention cost queries for patients who pay NHS charges in England versus those in Scotland, Wales and Northern Ireland who are usually exempt.

Some patients report delays in specialist approval for higher doses or maintenance prescriptions.

Positive Experiences:

• Faster relief for nocturnal reflux.
• Less worry about strict meal timing.
• Good availability in community pharmacies.

Negative Experiences:

• Mild gastrointestinal side effects.
• Concerns about long‑term magnesium and B12 effects.
• Cost and repeat prescription administrative delays in some cases.

Checklist For Reporting To Your Pharmacist Or GP:

• Describe symptom changes and timing (day/night).
• List any side effects and when they started.
• Bring current medicines list to check for interactions.

Buying Guide

Pharmacy Sources (Boots, LloydsPharmacy, Superdrug)

Where can patients collect Dexilant in the UK?

Dexilant and dexlansoprazole generics are prescription‑only and commonly dispensed by Boots, LloydsPharmacy and Superdrug, along with independent community and registered online pharmacies.

Always ask for a printed patient information leaflet and check the capsule strength on the packaging.

Pharmacies must dispense exactly as written on the prescription and pharmacists can answer questions on dosing, side effects and interactions.

Price Comparison (NHS Prescription Charge Vs Private)

How much will it cost on the NHS or privately?

On the NHS in England a prescription charge typically applies per item, though exemptions exist; prescriptions are generally free in Scotland, Wales and Northern Ireland.

Private prescription prices vary and branded Dexilant commonly costs more than generic dexlansoprazole.

For repeat prescriptions consider electronic repeat dispensing or pharmacy‑led prescription ordering services to save time.

In our online pharmacy, dexilant is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

What’s Inside & How It Works

Ingredients Overview

What exactly is in the capsule?

The active ingredient is dexlansoprazole (INN) in delayed‑release capsule form available as 30mg and 60mg strengths.

Excipients vary by manufacturer so check the patient information leaflet for allergens and full ingredient lists.

The capsule features a dual delayed‑release formulation with two separate releases in the gastrointestinal tract to extend acid suppression.

Mechanism Basics Explained Simply

How does dexlansoprazole reduce heartburn?

Dexlansoprazole blocks the gastric proton pumps (H+/K+ ATPase) in stomach parietal cells, reducing gastric acid secretion and allowing oesophageal healing in erosive disease.

Effects build over days for maximum benefit, though some patients feel relief within 24 to 48 hours.

The dual release system smooths acid suppression over a longer period than many single‑release PPIs and reduces dependence on exact meal timing.

Main Indications

Approved Uses (MHRA Listing)

What is Dexilant licensed to treat?

Licensed indications include symptomatic GERD treated with 30mg once daily, healing of erosive oesophagitis with 60mg once daily for up to eight weeks and maintenance of healed erosive oesophagitis with 30mg once daily for up to six months.

The product is approved for adolescents aged 12 years and over for the same indications where applicable.

Dexilant remains prescription‑only across the UK.

Off‑Label Uses In UK Clinics

When might clinicians try it outside the licence?

Off‑label use sometimes occurs for refractory reflux when other PPIs have failed and some specialists trial dexlansoprazole for symptom control in Barrett’s oesophagus, though this is not a licensed indication.

Always document informed consent for off‑label use and monitor clinical outcomes and adverse effects closely.

• Licensed Indications: Symptomatic GERD (30mg), Erosive Oesophagitis Healing (60mg), Maintenance (30mg).
• Off‑Label: Refractory reflux and selective specialist use in Barrett’s oesophagus with documented monitoring.
• Monitoring Needs: Symptom review after recommended course, magnesium and B12 checks for long‑term use, bone health review if risk factors exist.

Interaction Warnings

Food Interactions (Alcohol, Tea/Coffee)

Are there foods or drinks to avoid?

There are no major food interactions that prevent use with common UK foods and drinks, but alcohol can worsen reflux symptoms and should be reduced if it triggers symptoms.

Caffeinated drinks such as tea and coffee can provoke reflux in some people and are worth moderating alongside medication.

Weight management, avoiding late heavy meals and reducing known dietary triggers will improve symptom control in addition to medication.

Drug Conflicts (MHRA Yellow Card Reports)

Which medicines need checking with a pharmacist?

Avoid co‑administration with rilpivirine due to reduced antiviral levels and potential for treatment failure.

Monitor interactions with drugs whose absorption is affected by gastric pH such as atazanavir and some azole antifungals.

Be cautious with medicines metabolised by CYP enzymes that may be affected by PPIs, for example clopidogrel and warfarin, and adjust monitoring as necessary.

Report suspected interactions or adverse reactions via the MHRA Yellow Card scheme online or using the app.

Latest Evidence & Insights

Key UK & EU Studies 2022–2025

What do recent studies say about dual delayed‑release PPIs?

Recent UK and EU analyses from 2022–2025 have focused on comparative symptom control and real‑world persistence with dual delayed‑release PPIs.

Evidence suggests dexlansoprazole offers equivalent or improved night‑time symptom control for some patients and greater dosing flexibility compared with single‑release formulations.

Safety reviews continue to emphasise monitoring of long‑term PPI risks including low magnesium, vitamin B12 deficiency and effects on bone health.

Practical Takeaways For Patients

What should patients and clinicians do with this evidence?

Consider dexlansoprazole if meal timing or nocturnal reflux is problematic despite standard PPI therapy.

Review ongoing need for PPI therapy at regular intervals, and step down to the lowest effective dose when appropriate.

For prolonged therapy discuss magnesium, B12 and bone health risk factors with the clinician and arrange monitoring where clinically indicated.

• Dual delayed‑release formulations may improve night‑time control in some patients.
• Clinical decision should balance symptom control, cost and long‑term safety considerations.
• Periodic medication review and de‑prescribing after remission are recommended.

Alternative Choices

NHS Prescribing Alternatives With Pros/Cons Checklist

What are the common NHS alternatives?

Common alternatives include omeprazole, esomeprazole, lansoprazole and pantoprazole.

Pros: these are often cheaper, widely available as generics and have an established safety record, with omeprazole also available OTC for short‑term use.

Cons: some require stricter meal timing for optimal effect and may provide less overnight coverage than dexlansoprazole for certain patients.

When To Consider Switching

When might a clinician recommend a switch between PPIs?

Consider switching if a patient experiences intolerable side effects, inadequate symptom control on the current PPI, or significant cost or availability issues.

When switching, follow clinician guidance; an overlap or controlled titration period of 48–72 hours may be used in some cases to avoid symptom recurrence.

Regulation Snapshot

MHRA Approval & NHS Prescribing Framework

Is Dexilant regulated in the UK?

Dexlansoprazole is authorised in Europe and listed in regulatory databases and remains prescription‑only under major regulators according to the available data.

The ATC code is A02BC06 indicating its class among proton pump inhibitors for acid‑related disorders.

Prescribing should follow NHS formularies and local commissioning policies, and some local pathways may favour step‑therapy with a generic PPI first.

Prescription Status And Pharmacy Dispensing Notes

What should pharmacists document and advise?

Pharmacies must dispense per the prescription and supply the patient information leaflet with each dispensed item.

Report adverse events to the MHRA and ensure accurate records for repeats and eligibility for free prescriptions depending on the UK nation.

Prescriber Checklist:

• Confirm licensed indication, dose and duration.
• Document monitoring requirements for long‑term therapy.
• Counsel patients on storage, missed doses and when to seek further advice.

FAQ Section

Common UK Patient Questions

Q1: Can I stop Dexilant when symptoms settle?

A1: Discuss stopping with your GP or pharmacist; many stop after the recommended course and long‑term use should be regularly reviewed and stepped down when safe.

Q2: Is it safe during pregnancy?

A2: Discuss with your maternity team; many PPIs are used in pregnancy when benefits outweigh risks and local advice should guide therapy.

Q3: Will it interact with my blood thinner?

A3: Check with a clinician; interactions such as with warfarin may require monitoring of INR and dose adjustments.

Q4: Can I buy it over the counter?

A4: No, Dexilant and dexlansoprazole are prescription‑only in the available data.

Advise patients to report new muscle weakness, chest pain, severe diarrhoea or allergic reactions immediately and to use the MHRA Yellow Card scheme for adverse event reporting.

Guidelines For Proper Use

UK Pharmacist Counselling Style

How should a pharmacist counsel a patient collecting Dexilant?

Confirm name and strength (dexlansoprazole 30mg/60mg), explain the dosing schedule and duration, give missed‑dose instructions and storage advice to keep capsules below 30°C and dry.

Explain common side effects such as diarrhoea, nausea and headache and highlight critical interactions, especially with rilpivirine.

Use teach‑back: ask the patient to repeat how and when they will take the medicine to ensure understanding.

For chronic therapy arrange medication reviews and discuss checks for magnesium, vitamin B12 and bone health where applicable.

NHS Patient Support Advice

What written support should be provided?

Signpost patients to NHS.uk pages for general information and advise them to contact their GP for repeat prescriptions and local services for prescription ordering.

Provide a printed checklist on leaving the pharmacy showing dose, expected timeline for benefit, common side effects and when to seek urgent advice.

Delivery Across United Kingdom